INTL MEDICATION FDA Approval NDA 017701

NDA 017701

INTL MEDICATION

FDA Drug Application

Application #017701

Application Sponsors

NDA 017701INTL MEDICATION

Marketing Status

Discontinued001
Discontinued002

Application Products

001INJECTABLE;INJECTION2%0LIDOCAINE HYDROCHLORIDELIDOCAINE HYDROCHLORIDE
002INJECTABLE;INJECTION1%0LIDOCAINE HYDROCHLORIDELIDOCAINE HYDROCHLORIDE

FDA Submissions

TYPE 5; Type 5 - New Formulation or New ManufacturerORIG1AP1976-12-03STANDARD
LABELING; LabelingSUPPL6AP1985-08-23
LABELING; LabelingSUPPL8AP1986-01-15
LABELING; LabelingSUPPL9AP1986-06-30

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 17701
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.